Ane’ Orchard | Healthcare Applications | Best Researcher Award

Dr. Ane’ Orchard | Healthcare Applications | Best Researcher Award

Senior Lecturer at University of the Witwatersrand, South Africa

Dr. Ané Orchard is a dedicated pharmacist, academic, and senior lecturer at the University of the Witwatersrand with extensive experience in clinical pharmacy, pharmaceutical microbiology, and health sciences education. Her work bridges the gap between academic research and real-world public health outcomes, with a strong focus on probiotics, antimicrobial resistance, microbiome-linked diseases, and pharmacy education. She has led and contributed to numerous national and international research projects, demonstrating a strong commitment to advancing healthcare and education. Her ability to mentor students, lead collaborative research efforts, and publish in reputed journals highlights her as a well-rounded scholar. Recognized for her academic citizenship and public contributions, Dr. Orchard is committed to impactful and socially relevant research. Her ongoing projects and future plans reflect her dedication to driving change through scientific inquiry, collaboration, and innovation, making her a respected figure in the academic and healthcare research community.

Professional Profile 

Google Scholar | Scopus Profile | ORCID Profile 

Education

Dr. Ané Orchard pursued her higher education in pharmacy at the University of the Witwatersrand, where she completed both her undergraduate and doctoral studies. She has received rigorous training in pharmaceutical sciences, clinical pharmacy, microbiology, and health education, equipping her with a comprehensive foundation in both theoretical and applied aspects of pharmacy. Her academic journey reflects a strong commitment to lifelong learning, with a particular focus on integrating science and healthcare for community benefit. In addition to formal degrees, she has undertaken continuous professional development to stay current with advances in pharmaceutical practice and healthcare education. Her doctoral research laid the groundwork for her current interdisciplinary studies that span clinical practice, microbiology, and public health. Through her education, she has developed the critical thinking and research skills necessary to address pressing challenges in healthcare and pharmacy education, laying a solid platform for her contributions to academia and research.

Professional Experience

Dr. Ané Orchard has built a dynamic professional career centered around academic teaching, research, and public health impact. As a senior lecturer at the University of the Witwatersrand, she has been instrumental in developing and delivering curriculum in clinical pharmacy, pharmaceutical microbiology, and health sciences education. Her responsibilities extend beyond classroom teaching to include student mentorship, supervision of postgraduate research, and academic leadership in collaborative projects. She has led multiple research initiatives aimed at improving patient outcomes and advancing pharmacy practice. Her involvement in international collaborations, such as the Una Europa – Africa Partnership, showcases her ability to work across borders and disciplines. In addition to her academic role, she contributes to institutional development by participating in quality assurance, curriculum review, and community outreach. Her professional journey reflects a strong alignment between research excellence, educational impact, and a broader vision of healthcare improvement through evidence-based practices.

Research Interest

Dr. Ané Orchard’s research interests span a broad and interdisciplinary range that includes clinical pharmacy, pharmaceutical microbiology, public health, and health sciences education. She is particularly focused on the role of probiotics, antimicrobial resistance, and microbiome-related diseases, contributing to a deeper understanding of how these elements affect patient health and therapeutic strategies. Her research also explores innovations in pharmacy education, aiming to enhance the training of future healthcare professionals through evidence-based teaching methods. Additionally, she is engaged in public health-focused studies that address community health challenges in resource-constrained environments. Her commitment to applied, socially relevant research has driven her involvement in international collaborations aimed at addressing global health concerns. Dr. Orchard continues to investigate how natural products and medicinal chemistry can be integrated into therapeutic solutions. Her interdisciplinary approach ensures that her research contributes to both scientific advancement and practical improvements in healthcare delivery and education.

Award and Honor

Dr. Ané Orchard has received several honors and awards in recognition of her academic excellence, research contributions, and public service. She was selected as one of the Mail and Guardian’s 200 Young South Africans, a prestigious recognition celebrating individuals making a significant impact in their respective fields. She has also been honored with her university’s Academic Citizenship Award, acknowledging her dedication to institutional service, student mentorship, and research excellence. Her work has received accolades at both national and international conferences, where she has earned awards for best presentations and scientific posters. These achievements reflect her ability to communicate research findings effectively and contribute meaningfully to academic discourse. Her consistent recognition is a testament to her leadership in the field of pharmacy and health sciences. Through these awards, Dr. Orchard’s influence in education, research, and public engagement is validated, and she continues to inspire peers and students alike with her dedication and professionalism.

Research Skill

Dr. Ané Orchard possesses a comprehensive set of research skills that span both qualitative and quantitative methodologies, making her well-equipped for interdisciplinary scientific inquiry. She is proficient in designing and managing clinical and laboratory-based research studies, particularly in the areas of pharmaceutical microbiology, probiotics, and public health. Her skills include advanced data analysis, statistical evaluation, systematic reviews, and scientific writing for publication in peer-reviewed journals. She is adept at research ethics compliance, proposal writing, and grant applications, reflecting her capability to lead and sustain funded research projects. Her involvement in collaborative international studies has enhanced her ability to coordinate multi-site research and contribute to cross-disciplinary innovation. Dr. Orchard is also skilled in mentoring students and junior researchers, supporting their development in academic writing, critical thinking, and experimental design. Her research competencies are continually updated through professional development, ensuring relevance and rigor in her approach to addressing health-related scientific challenges.

Publications Top Notes

Title: Commercial essential oils as potential antimicrobials to treat skin diseases
Authors: A Orchard, S van Vuuren
Year: 2017
Citations: 323

Title: The in vitro Antimicrobial Activity and Chemometric Modelling of 59 Commercial Essential Oils against Pathogens of Dermatological Relevance
Authors: A Orchard, M Sandasi, G Kamatou, A Viljoen, S van Vuuren
Year: 2017
Citations: 89

Title: The influence of carrier oils on the antimicrobial activity and cytotoxicity of essential oils
Authors: A Orchard, G Kamatou, AM Viljoen, N Patel, P Mawela, SF Vuuren
Year: 2019
Citations: 79

Title: The in vitro antimicrobial evaluation of commercial essential oils and their combinations against acne
Authors: A Orchard, SF Van Vuuren, AM Viljoen, G Kamatou
Year: 2018
Citations: 55

Title: A scoping review of African natural products against gastric ulcers and Helicobacter pylori
Authors: S Dinat, A Orchard, S Van Vuuren
Year: 2023
Citations: 38

Title: Wound pathogens: Investigating antimicrobial activity of commercial essential oil combinations against reference strains
Authors: A Orchard, A Viljoen, S van Vuuren
Year: 2018
Citations: 29

Title: Carrier oils in dermatology
Authors: A Orchard, SF van Vuuren
Year: 2019
Citations: 27

Title: Commercial essential oil combinations against topical fungal pathogens
Authors: A Orchard, SF van Vuuren, AM Viljoen
Year: 2019
Citations: 23

Title: Antimicrobial essential oil combinations to combat foot odour
Authors: A Orchard, A Viljoen, S van Vuuren
Year: 2018
Citations: 18

Title: High prevalence but lack of awareness of hypertension in South Africa, particularly among men and young adults
Authors: AJ Woodiwiss, A Orchard, CMC Mels, AS Uys, BN Nkeh-Chungag, …
Year: 2025
Citations: 13

Conclusion

Dr. Ané Orchard is a deserving candidate for the Best Researcher Award due to her impactful contributions to clinical pharmacy, pharmaceutical microbiology, and health sciences education. Her research has significantly advanced understanding in areas such as probiotics, antimicrobial resistance, and public health, while also contributing to the academic development of future healthcare professionals. Through her leadership in research projects and recognition for academic citizenship, she has demonstrated a strong commitment to both scientific excellence and societal impact. With her ongoing projects and potential for expanded interdisciplinary and international collaboration, she is well positioned for continued leadership and innovation in her field.

Prof Dr. Michael Linnebacher | Healthcare Applications | Best Researcher Award

Prof Dr. Michael Linnebacher | Healthcare Applications | Best Researcher Award

Prof Doctorate at Universitätsmedizin Rostock, Germany 

Profiles

Scopus

Orcid

Summary:

Prof Dr. Michael Linnebacher, born on July 5, 1969, in Ottweiler, Germany, is a prominent researcher in molecular oncology and immunotherapy. He serves as the Laboratory and Research Director at the Clinic for General Surgery, University Medicine Rostock. Linnebacher’s career spans significant contributions to the understanding and treatment of gastrointestinal tumors, particularly focusing on immunotherapy and the role of microsatellite instability in cancer.

Education

Prof Dr. Linnebacher holds a Diploma in Biology from the University of Saarland (1996) and completed his PhD in Biology at the Technical University of Karlsruhe in 2001. His academic training includes extensive research on immunogenic neo-peptides and tumor antigens, setting a strong foundation for his career in oncology and immunotherapy.

💼 Professional Experience

  • 1996-1997: Research assistant, Heidelberg University Biochemistry Center
  • 1998-2001: PhD student, Institute of Immunology, Ruprecht-Karls-University Heidelberg
  • 2001-2005: Postdoctoral research, University Hospital Heidelberg, Department of Molecular Pathology
  • 2005-Present: Laboratory Director, Molecular Oncology and Immunotherapy, Clinic for General Surgery, University Medical Center Rostock
  • 2009: Venia legendi (Privatdozent)
  • 2010: Junior Professor for Immunology and Infectiology, University of Saarland
  • 2012: Professor for Translational Surgical Oncology and Biobanking, University of Lübeck
  • 2020-Present: Managing Director, BioBank Rostock; Member of the German Biobank Alliance

🔬 Research Interests

  • Immunotherapy and its applications in cancer treatment
  • Microsatellite instability and its role in tumor antigen development
  • Translational research in oncology
  • Biobanking and its role in cancer research and treatment

 

Publications

Peptide-stimulated T cells bypass immune checkpoint inhibitor resistance and eliminate autologous microsatellite instable colorectal cancer cells

  • Authors: Schwarz, S., Su, Z., Krohn, M., Schlosser, A., Linnebacher, M.
  • Journal: npj Precision Oncology
  • Year: 2024
  • Authors: Edelmann, M., Fan, S., De Oliveira, T., Rieken, S., Conradi, L.-C.
  • Journal: Cancer Research Communications
  • Year: 2024

Transcriptome-wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancer

  • Authors: Mariella, E., Grasso, G., Miotto, M., Di Nicolantonio, F., Bardelli, A.
  • Journal: Molecular Oncology
  • Year: 2024

SKP2 promotes the metastasis of pancreatic ductal adenocarcinoma by suppressing TRIM21-mediated PSPC1 degradation

  • Authors: Yuan, J., Zhu, Z., Zhang, P., Gong, P., Zhang, X.
  • Journal: Cancer Letters
  • Year: 2024

A glutamatergic biomarker panel enables differentiating Grade 4 gliomas/astrocytomas from brain metastases

  • Authors: Lange, F., Gade, R., Einsle, A., Freiman, T.M., Kirschstein, T.
  • Journal: Frontiers in Oncology
  • Year: 2024

Ms. Rebekah Fretwell | Healthcare Applications | Best Researcher Award

Ms. Rebekah Fretwell | Healthcare Applications | Best Researcher Award

Rebekah Fretwell at Sheffield Teaching Hospitals NHS Foundation Trust, United Kingdom

Profile

Scopus

Education

  • Doctorate Degree: Thesis submission due December 2024
  • MSc Pathological Sciences: University of Sheffield, 2005
  • BSc (Hons) Medicine & Pharmacology: University of Sheffield, 2003
  • A-Levels: Biology, Chemistry, English Literature, General Studies (1999)
  • GCSEs: 13 subjects including Biology, Chemistry, and Mathematics (1997)

💼 Professional Experience

  • Current Position: Senior Specialist Biomedical Scientist in Coagulation; ADAMTS-13 Section Lead; Lead Training Manager at Royal Hallamshire Hospital and Northern General Hospital, Sheffield
  • Past Roles: Union Representative for Department of Medicine & Pharmacology, University of Sheffield (2001-2003)

🔬 Research Interests

  • Recent Projects:
    • Developing automated ADAMTS-13 activity assays (2023-2024) 
    • Assessing Factor Xa inhibitors and their reversal (2012-present) 
    • Evaluating effects of Direct Thrombin Inhibitors (2004-2005) 
  • Key Contributions:
    • Setting up ADAMTS-13 activity and antibody assays 
    • Research into FVIII Inhibitor assays and new anticoagulant therapies 

🌐 Professional Membership

  • Member: Institute of Biomedical Science (MIBMS) 

📚 Teaching and Mentoring

  • Lecturer: BSc & MSc courses at University of Sheffield, Sheffield Hallam University, and Bradford University 
  • Practice Tutor/Assessor: University of Hull, supervising and assessing students in biomedical science placements

 

Publications

Practical Considerations for the Use of the Rapid AcuStar® ADAMTS13 Activity Assay in the Diagnosis of Acute Thrombotic Thrombocytopenic Purpura (TTP)

  • Authors: Yong, J., MacDonald, S., Downey, C., Pitchford, T., Dutt, T.
  • Journal: Journal of Clinical Medicine
  • Year: 2024
  • Authors: Sumaya, W., Parker, W.A.E., Fretwell, R., Ajjan, R.A., Storey, R.F.
  • Journal: Thrombosis and Haemostasis
  • Year: 2018

Multiple Centre Evaluation Study of ADAMTS13 Activity and Inhibitor Assays

  • Authors: Langley, K., Fretwell, R., Kitchen, S., Murphy, P., Scully, M.
  • Journal: International Journal of Laboratory Hematology
  • Year: 2018

Dr. Yuki Higashimoto | Healthcare Applications | Best Researcher Award

Dr. Yuki Higashimoto | Healthcare Applications | Best Researcher Award

Doctorate at Fujita Health University, Japan

Profiles

Orcid

Education

Dr. Yuki completed his primary education with 6 years in primary school, followed by 3 years in junior high school and 3 years in senior high school. He pursued his university education at Fujita Health University School of Health Sciences from 2003 to 2007. He continued his graduate studies at Fujita Health University Graduate School of Health Sciences, earning his Master’s degree from 2007 to 2009. He later obtained his Doctor of Philosophy in Medicine (PhD) in September 2018 from the Graduate School of Medicine, Fujita Health University.

Professional Experience

From 2009 to 2017, Dr. Yuki worked as a Medical Technologist in the Department of Clinical Laboratory at Fujita Health University Hospital, Toyoake, Aichi, Japan. He served as an Assistant Professor at the Faculty of Medical Technology, Fujita Health University, from 2017 to August 2021. Additionally, he continued as a Medical Technologist at Fujita Health University Hospital until 2022.

📚 Teaching and Academic Appointments

Since September 2021, Dr. Yuki has held the position of Senior Assistant Professor of Clinical Microbiology and Clinical Immunology at the Faculty of Medical Technology, Fujita Health University, Toyoake, Aichi, Japan.

🏆 Honors and Awards

In 2018, Dr. Yuki received the Young Scientist Incentive Award from The Japanese Society of Clinical Virology.

🔬 Professional Memberships

Dr. Yuki is an active member of several professional organizations, including The Japanese Society for Virology, The Japanese Society of Clinical Virology, The Japanese Society of Vaccinology, The Japanese Society for Clinical Microbiology, The Japan Association for Clinical Laboratory Science, and the Japanese Society of Food Science and Risk Analysis.

 Publications

Generation of Recombinant Authentic Live Attenuated Human Rotavirus Vaccine Strain RIX4414 (Rotarix<sup>®</sup>) from Cloned cDNAs Using Reverse Genetics
  • Authors: Saori Fukuda, Masanori Kugita, Kanako Kumamoto, Yuki Akari, Yuki Higashimoto, Shizuko Nagao, Takayuki Murata, Tetsushi Yoshikawa, Koki Taniguchi, Satoshi Komoto
  • Journal: Viruses
  • Year: 2024
Andrographolide, isolated from Andrographis paniculata, induces apoptosis in monocytic leukemia and multiple myeloma cells via augmentation of reactive oxygen species production
  • Authors: Doi H, Matsui T, Dijkstra JM, Ogasawara A, Higashimoto Y, Imamura S, Ohye T, Takematsu H, Katsuda I, Akiyama H
  • Journal: F1000Research
  • Year: 2021
Diagnostic accuracy of LAMP versus PCR over the course of SARS-CoV-2 infection
  • Authors: Inaba M, Higashimoto Y, Toyama Y, Horiguchi T, Hibino M, Iwata M, Imaizumi K, Doi Y
  • Journal: International Journal of Infectious Diseases
  • Year: 2021
Evaluation of varicella vaccine effectiveness during outbreaks in schools or nurseries by cross-sectional study
  • Authors: Kawamura Y, Hattori F, Higashimoto Y, Kozawa K, Yoshikawa T
  • Journal: Vaccine
  • Year: 2021
Dry loop–mediated isothermal amplification assay for detection of SARS-CoV-2 from clinical specimens
  • Authors: Higashimoto Y, Ihira M, Kawamura Y, Inaba M, Shirato K, Suzuki T, Hasegawa H, Kageyama T, Doi Y, Hata T et al.
  • Journal: Preprint
  • Year: 2020